Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1672650401;50402;50403 chr2:178612349;178612348;178612347chr2:179477076;179477075;179477074
N2AB1508545478;45479;45480 chr2:178612349;178612348;178612347chr2:179477076;179477075;179477074
N2A1415842697;42698;42699 chr2:178612349;178612348;178612347chr2:179477076;179477075;179477074
N2B766123206;23207;23208 chr2:178612349;178612348;178612347chr2:179477076;179477075;179477074
Novex-1778623581;23582;23583 chr2:178612349;178612348;178612347chr2:179477076;179477075;179477074
Novex-2785323782;23783;23784 chr2:178612349;178612348;178612347chr2:179477076;179477075;179477074
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCT
  • RefSeq wild type template codon: CGA
  • Domain: Fn3-9
  • Domain position: 76
  • Structural Position: 109
  • Q(SASA): 0.0716
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/T None None 1.0 N 0.719 0.381 0.310147130316 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.7847 likely_pathogenic 0.7191 pathogenic -1.195 Destabilizing 1.0 D 0.701 prob.neutral None None None None N
A/D 0.9964 likely_pathogenic 0.9956 pathogenic -2.619 Highly Destabilizing 1.0 D 0.801 deleterious D 0.63957044 None None N
A/E 0.9857 likely_pathogenic 0.981 pathogenic -2.334 Highly Destabilizing 1.0 D 0.791 deleterious None None None None N
A/F 0.9428 likely_pathogenic 0.9126 pathogenic -0.759 Destabilizing 1.0 D 0.799 deleterious None None None None N
A/G 0.5325 ambiguous 0.5125 ambiguous -2.17 Highly Destabilizing 1.0 D 0.644 neutral D 0.576038132 None None N
A/H 0.9775 likely_pathogenic 0.9652 pathogenic -2.322 Highly Destabilizing 1.0 D 0.765 deleterious None None None None N
A/I 0.962 likely_pathogenic 0.9405 pathogenic -0.238 Destabilizing 1.0 D 0.801 deleterious None None None None N
A/K 0.9822 likely_pathogenic 0.975 pathogenic -1.143 Destabilizing 1.0 D 0.799 deleterious None None None None N
A/L 0.8564 likely_pathogenic 0.7943 pathogenic -0.238 Destabilizing 1.0 D 0.76 deleterious None None None None N
A/M 0.8854 likely_pathogenic 0.8242 pathogenic -0.698 Destabilizing 1.0 D 0.745 deleterious None None None None N
A/N 0.9807 likely_pathogenic 0.9726 pathogenic -1.71 Destabilizing 1.0 D 0.811 deleterious None None None None N
A/P 0.999 likely_pathogenic 0.999 pathogenic -0.682 Destabilizing 1.0 D 0.801 deleterious D 0.640887409 None None N
A/Q 0.9318 likely_pathogenic 0.8949 pathogenic -1.333 Destabilizing 1.0 D 0.795 deleterious None None None None N
A/R 0.936 likely_pathogenic 0.8989 pathogenic -1.45 Destabilizing 1.0 D 0.799 deleterious None None None None N
A/S 0.3959 ambiguous 0.3566 ambiguous -2.045 Highly Destabilizing 1.0 D 0.638 neutral N 0.442974148 None None N
A/T 0.7966 likely_pathogenic 0.7397 pathogenic -1.632 Destabilizing 1.0 D 0.719 prob.delet. N 0.470581092 None None N
A/V 0.8457 likely_pathogenic 0.8021 pathogenic -0.682 Destabilizing 1.0 D 0.675 prob.neutral N 0.480588138 None None N
A/W 0.9944 likely_pathogenic 0.9891 pathogenic -1.42 Destabilizing 1.0 D 0.784 deleterious None None None None N
A/Y 0.9759 likely_pathogenic 0.9601 pathogenic -1.053 Destabilizing 1.0 D 0.79 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.